Skip to main content
. 2020 Oct 23;28(5):2632–2645. doi: 10.1245/s10434-020-09214-x

Fig. 2.

Fig. 2

Nomogram to predict the pathological outcomes of NCT. HER2 human epidermal growth factor receptor 2, LVI lymphovascular invasion, NCT neoadjuvant chemotherapy, ER estrogen receptor